Navigation Links
SIRO Clinpharm Expands Footprint in India with New Hyderabad Office
Date:11/11/2014

MUMBAI, India, November 11, 2014 /PRNewswire/ --

SIRO Clinpharm, an award-winning Clinical Research Organization (CRO) headquartered in Mumbai, announces the opening of its new office in Hyderabad, India. After successful expansions through partnerships in Asia, SIRO Clinpharm further expands its footprint in India and consolidates its position as the preferred clinical development partner to the global pharmaceutical industry.

     (Logo: http://photos.prnewswire.com/prnh/20130510/613364)

"Hyderabad has always had a vibrant biopharmaceutical ecosystem and we believe that SIRO Clinpharm can actively contribute to the global industry with the expansion of our local operations. With our expanding footprint, we broaden our value proposition and bring a unique competitive advantage to the table," said Partha Chatterjee, Head - Clinical Research and Clinical Trial Supplies Management.

A continuous emphasis on developing and retaining talented people remains SIRO Clinpharm's key driver of success. "The clinical research industry has its niche which requires specialized talent and Hyderabad, being a life-sciences hub, attracts highly qualified professionals from across the country. Our new office gives us access to this talent pool which is imperative to ensure that we are providing our clients with world-class services," said Dr. Vatsal Shah, Vice President & Global Head - Medical Writing, Biometrics & Pharmacovigilance.

As one of the largest medical writing agencies in Asia, SIRO Clinpharm offers high-quality, cost-efficient and flexible solutions. In addition to its wide operational presence across the globe, SIRO also has access to a large database of investigators and is one of the few CROs to have a dedicated feasibility team. This unique blend of service portfolio coupled with customer focus has helped SIRO adapt to the dynamic clinical development scenario.

About SIRO Clinpharm
SIRO Clinpharm, winner of Frost & Sullivan "Clinical Research Organization of the Year" Healthcare Award is a drug development solutions provider to the global healthcare industry. Our subject expertise gives us an edge in clinical trial management, clinical data management, medical writing, biostatistics and statistical programming pharmacovigilance and clinical trial supplies management. We offer flexible business models across service verticals based on client needs. Visit us at http://www.siroclinpharm.com.


'/>"/>
SOURCE SIRO Clinpharm
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. SIRO Clinpharm Announces a Fabulous Date With the Dueling Pianos
2. PAREXEL Expands Clinical Trial Supply And Logistics Services Through Opening Of New European Coordination Hub and Distribution Center
3. Surefire Medicals Scientific Advisory Board Expands, Broadens Clinical Trial Expertise
4. Cardica Expands Board of Directors With Appointment of Two Experienced Medical Device Executives
5. Trovagene Expands Clinical Program with New Study Evaluating its Precision Cancer Monitoring Platform in Lung Cancer
6. Chiltern acquires Pacific Clinical Research Pte Limited and expands operations and therapeutic depth in Asia-Pacific
7. Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers
8. ImaginAb Expands ImmunoPET Pipeline to Include CD4+ T-Cell Imaging
9. Mediquip Home Care Expands Services to Federal Agencies, Will Seek GSA
10. Colorado Eye Care: Vision Care Specialists Expands Hours, adds Optometrists to Denver Locations
11. Cephasonics Expands Lineup of cQuest Research Systems with New Firebird and Griffin Higher Channel-Count Models for Medical and Industrial Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2020)... (PRWEB) , ... September 01, 2020 , ... ... has been appointed to serve as Secretary to the Board of Trustees and ... , Mile High United Way is a Denver-based nonprofit organization that fights for ...
(Date:9/1/2020)... ... September 01, 2020 , ... Breast and ovarian cancers are common diseases that ... of breast cancers (about 7,500 women per year) and 10% of ovarian cancers (about ... Both genes are detectable in the Women’s Excellence Genetic Testing Program. , Dr. ...
(Date:8/31/2020)... ... August 31, 2020 , ... Welltech1, the first Israeli ... have invested $400,000 in PopBase, one of two start-ups that beat 152 companies ... Institute (GWI). , The competition was part of the GWI’s The Wellness ...
Breaking Medicine Technology:
(Date:9/3/2020)... TAMPA, Fla. (PRWEB) , ... September 03, 2020 ... ... today announced it is sponsoring the American Foundation for Suicide Prevention’s (AFSP) annual ... of a million people across hundreds of U.S. cities to raise awareness of ...
(Date:9/2/2020)... ... September 02, 2020 , ... RAM Technologies, Inc., the ... Advantage and Special Needs plans, is proud to support the 2020 National Conferences ... RAM is supporting the event as a sponsor and exhibitor and will be ...
(Date:9/1/2020)... ... 2020 , ... Dr. Kiran Gill is a Board Certified ... face, breast, and body. In 2018, she founded Aesthetics in Plastic Surgery by ... practice in Southwest Florida. Dr. Gill and her team offer surgical and non-surgical ...
(Date:8/31/2020)... ... , ... Want to get moving, break up your routine, and make a ... to launch its fourth annual STEPtember campaign in the United States to raise funds ... they are at this moment — encouraging people to move in the ways that ...
(Date:8/31/2020)... ... August 31, 2020 , ... A Cure for Covid-19 “PTS” with Mediation & Hypnosis , ... in a state of panic, experiencing deep anxiety, immense stress, and right now are needing ... timely when most people on the planet are experiencing a great degree of emotional discomfort, ...
Breaking Medicine News(10 mins):